63Zn was produced in a low-energy cyclotron (GE PETtrace, GE HealthCare, Waukesha, WI) via the 63Cu(p, n)63Zn reaction in an in-house-developed solution target, as previously described.12 (link) The final product, 63Zn-zinc citrate was prepared using an isotonic 4% sodium citrate United States Pharmacopeia solution (Fenwal Inc, Lake Zurich, Illinois) and passed standard quality control tests for Current Good Manufacturing Practice for radiopharmaceutical production.12 (link) Specific activity of 63Zn in the radiopharmaceutical product was 19.4 ± 14.6 GBq/μmol at the end of synthesis. Iron and copper ions were present at concentrations of 2.7 ± 2.5 mg/L and 0.18 ± 0.16 mg/L, respectively. Injection volumes ranged from 3 to 7 mL.
Ge pettrace
The GE PETtrace is a compact and versatile cyclotron system designed for the production of positron emission tomography (PET) radioisotopes. It is capable of accelerating protons to high energies, enabling the synthesis of a range of PET tracers used in medical imaging applications.
3 protocols using ge pettrace
Production and Formulation of 63Zn-Zinc Citrate
63Zn was produced in a low-energy cyclotron (GE PETtrace, GE HealthCare, Waukesha, WI) via the 63Cu(p, n)63Zn reaction in an in-house-developed solution target, as previously described.12 (link) The final product, 63Zn-zinc citrate was prepared using an isotonic 4% sodium citrate United States Pharmacopeia solution (Fenwal Inc, Lake Zurich, Illinois) and passed standard quality control tests for Current Good Manufacturing Practice for radiopharmaceutical production.12 (link) Specific activity of 63Zn in the radiopharmaceutical product was 19.4 ± 14.6 GBq/μmol at the end of synthesis. Iron and copper ions were present at concentrations of 2.7 ± 2.5 mg/L and 0.18 ± 0.16 mg/L, respectively. Injection volumes ranged from 3 to 7 mL.
Production and Purification of [18F]Fluoride
11C-Methionine PET Brain Imaging Protocol
To minimize potential confounding effects, patients were instructed to limit physical activity, followed by a 10 min rest period post-injection. Approximately 10 min after injection, low-dose transmission CT images were acquired to facilitate brain attenuation correction for the PET emission data and provide morphological information.
Whole-brain emission data were acquired in three-dimensional mode, 15–20 min post-injection of 11C-MET, utilizing a Philips Vereos Digital PET/CT scanner (Philips Healthcare, Amsterdam, the Netherlands). This comprehensive imaging protocol ensured optimal visualization and quantification of metabolic activity within the brain tissue.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!